These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 8642986)
21. Vitamin E in the treatment of tardive dyskinesia: a replication study. Lam LC; Chiu HF; Hung SF J Nerv Ment Dis; 1994 Feb; 182(2):113-4. PubMed ID: 8308529 [No Abstract] [Full Text] [Related]
24. Vitamin E in the treatment of tardive dyskinesia. Boomershine KH; Shelton PS; Boomershine JE Ann Pharmacother; 1999 Nov; 33(11):1195-202. PubMed ID: 10573320 [TBL] [Abstract][Full Text] [Related]
25. The treatment of tardive dyskinesia and tardive dystonia. Simpson GM J Clin Psychiatry; 2000; 61 Suppl 4():39-44. PubMed ID: 10739330 [TBL] [Abstract][Full Text] [Related]
26. The effect of vitamin E treatment on tardive dyskinesia and blood superoxide dismutase: a double-blind placebo-controlled trial. Zhang XY; Zhou DF; Cao LY; Xu CQ; Chen DC; Wu GY J Clin Psychopharmacol; 2004 Feb; 24(1):83-6. PubMed ID: 14709952 [TBL] [Abstract][Full Text] [Related]
27. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia. Lohr JB; Caligiuri MP J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552 [TBL] [Abstract][Full Text] [Related]
28. Systematic review of cholinergic drugs for neuroleptic-induced tardive dyskinesia: a meta-analysis of randomized controlled trials. Tammenmaa IA; Sailas E; McGrath JJ; Soares-Weiser K; Wahlbeck K Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1099-107. PubMed ID: 15610922 [TBL] [Abstract][Full Text] [Related]
34. [Vitamin E is ineffective in treatment of late dyskinesias]. Bridler R Praxis (Bern 1994); 2001 May; 90(18):809-10. PubMed ID: 11392285 [No Abstract] [Full Text] [Related]
35. Clonazepam treatment of tardive dyskinesia: a practical GABAmimetic strategy. Thaker GK; Nguyen JA; Strauss ME; Jacobson R; Kaup BA; Tamminga CA Am J Psychiatry; 1990 Apr; 147(4):445-51. PubMed ID: 1969244 [TBL] [Abstract][Full Text] [Related]
37. Partial reversal of the iminodipropionitrile-induced hyperkinetic syndrome in rats by alpha-tocopherol (vitamin E). Lohr JB; Cadet JL; Wyatt RJ; Freed WJ Neuropsychopharmacology; 1988 Dec; 1(4):305-9. PubMed ID: 3251508 [TBL] [Abstract][Full Text] [Related]
38. Reliability of an instrumental assessment of tardive dyskinesia: results from VA Cooperative Study #394. Caligiuri MP; Lohr JB; Rotrosen J; Adler L; Lavori P; Edson R; Tracy K Psychopharmacology (Berl); 1997 Jul; 132(1):61-6. PubMed ID: 9272760 [TBL] [Abstract][Full Text] [Related]
39. Pharmacologic probes of neurotransmitter systems in tardive dyskinesia: implications for clinical management. Nasrallah HA; Dunner FJ; McCalley-Whitters M; Smith RE J Clin Psychiatry; 1986 Feb; 47(2):56-9. PubMed ID: 3003037 [TBL] [Abstract][Full Text] [Related]